FDA Inspection
Boehringer Ingelheim Pharmaceuticals, Inc.FDA Inspection 1112627 - Boehringer Ingelheim Pharmaceuticals, Inc. - December 12, 2019
Discuss this record with AI
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on December 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 3cec078a-63a0-4054-aba3-a7b39a8fad4e
Violation Codes3
21 CFR 312.5021 CFR 312.56(b)21 CFR 312.57(c)
Full citation text and observation details available on the Dashboard.